John Applegate is the Chief Financial Officer at Zephyr AI, bringing over 25 years of financial and strategic expertise in the biotechnology sector. An alumnus of Harvard Business School and Northwestern University, he has a history of driving growth at AI-driven drug discovery companies, including Verge Genomics and Valo Health.
No publicly available information was found regarding Johns personal life, hobbies, or interests outside of his extensive and successful professional career in biotechnology and finance.
During his 14-year tenure at Biogen, John managed the critical Alzheimers disease drug development collaboration with Eisai and the oncology blockbuster RITUXAN® alliance with Genentech.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.